IN8bio Statistics
Share Statistics
IN8bio has 72.48M shares outstanding. The number of shares has increased by 67.45% in one year.
| Shares Outstanding | 72.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 54.92% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 57.73M |
| Failed to Deliver (FTD) Shares | 3.40K |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 1.00M, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 1.00M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.74% |
| Short Ratio (days to cover) | 0.51 |
Valuation Ratios
The PE ratio is -1.37 and the forward PE ratio is -1.17.
| PE Ratio | -1.37 |
| Forward PE | -1.17 |
| PS Ratio | 0 |
| Forward PS | 0.5 |
| PB Ratio | 1.65 |
| P/FCF Ratio | -1.72 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for IN8bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.
| Current Ratio | 4.57 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.2% and return on capital (ROIC) is -101.7%.
| Return on Equity (ROE) | -1.2% |
| Return on Assets (ROA) | -0.89% |
| Return on Capital (ROIC) | -101.7% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -769.41K |
| Employee Count | 39 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -78.08% in the last 52 weeks. The beta is -0.07, so IN8bio 's price volatility has been lower than the market average.
| Beta | -0.07 |
| 52-Week Price Change | -78.08% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 1.39M |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.50M |
| Operating Income | -30.34M |
| Net Income | -30.01M |
| EBITDA | -28.50M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1 |
Balance Sheet
The company has 21.28M in cash and 4.89M in debt, giving a net cash position of 16.39M.
| Cash & Cash Equivalents | 21.28M |
| Total Debt | 4.89M |
| Net Cash | 16.39M |
| Retained Earnings | -91.22M |
| Total Assets | 15.97M |
| Working Capital | 3.07M |
Cash Flow
In the last 12 months, operating cash flow was -23.34M and capital expenditures -600.00K, giving a free cash flow of -23.94M.
| Operating Cash Flow | -23.34M |
| Capital Expenditures | -600.00K |
| Free Cash Flow | -23.94M |
| FCF Per Share | -0.8 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -312.5% |
| FCF Yield | -104.49% |
Analyst Forecast
The average price target for INAB is $7.5, which is 2243.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.5 |
| Price Target Difference | 2243.8% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -14.07 |
| Piotroski F-Score | 2 |